Quoin Pharmaceuticals Ltd. SEC filings QNRX
Quoin Pharmaceuticals Ltd. has 583 filings in SEC EDGAR's recent list, going back to Apr 8, 2016. Its latest annual report, Form ARS, was filed on Jul 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement).
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 4, 2026 | — |
| EFFECT | Filing | Sep 25, 2026 | — |
| D | Filing | Sep 10, 2026 | — |
| EFFECT | Filing | Dec 4, 2025 | — |
| CORRESP | Letter to the SEC | Dec 2, 2025 | — |
| D | Filing | Oct 23, 2025 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 17, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| EFFECT | Filing | Apr 3, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| EFFECT | Filing | Mar 17, 2023 | — |
| EFFECT | Filing | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2023 | — |
| D | Filing | Aug 31, 2022 | — |
| POS EX | Filing | Aug 11, 2022 | — |
| EFFECT | Filing | Aug 5, 2022 | — |
| CORRESP | Letter to the SEC | Aug 4, 2022 | — |
| CORRESP | Letter to the SEC | Aug 4, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2022 | — |
| RW | Filing | Jun 30, 2022 | — |
| EFFECT | Filing | Apr 22, 2022 | — |
| CORRESP | Letter to the SEC | Apr 22, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2022 | — |
| EFFECT | Filing | Aug 12, 2021 | — |
| CORRESP | Letter to the SEC | Aug 10, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| 25-NSE | Delisting notice | Aug 3, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2021 | — |
| CORRESP | Letter to the SEC | Jul 16, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2021 | — |
| EFFECT | Filing | Apr 4, 2019 | — |
| EFFECT | Filing | Feb 7, 2019 | — |
| CORRESP | Letter to the SEC | Feb 6, 2019 | — |
| CORRESP | Letter to the SEC | Feb 6, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2019 | — |
| EFFECT | Filing | Aug 21, 2018 | — |
| EFFECT | Filing | Apr 6, 2018 | — |
| D | Filing | Feb 9, 2018 | — |
| EFFECT | Filing | Feb 8, 2018 | — |
| CORRESP | Letter to the SEC | Feb 7, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2018 | — |
| D | Filing | Sep 19, 2017 | — |
| EFFECT | Filing | Aug 17, 2017 | — |
| CORRESP | Letter to the SEC | Aug 16, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2017 | — |
| EFFECT | Filing | Aug 9, 2017 | — |
| EFFECT | Filing | Apr 6, 2017 | — |
| RW | Request for withdrawal | Aug 3, 2016 | — |
| CERTNAS | Auto-generated paper document | Jul 29, 2016 | — |
| EFFECT | Filing | Jul 28, 2016 | — |
| CORRESP | Letter to the SEC | Jul 27, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2016 | — |
| 8-A12B | Filing | Jul 27, 2016 | — |
| CORRESP | Letter to the SEC | Jul 26, 2016 | — |
| CORRESP | Letter to the SEC | Jul 26, 2016 | — |
| CORRESP | Letter to the SEC | Jul 22, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2016 | — |
| DRSLTR | Filing | Jul 1, 2016 | — |
| DRS/A | Filing | Jul 1, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2016 | — |
| DRS/A | Filing | May 26, 2016 | — |
| DRSLTR | Filing | May 25, 2016 | — |
| UPLOAD | Letter from the SEC | May 6, 2016 | — |
| DRS | Filing | Apr 8, 2016 | — |
Showing 72 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QNRX (Nasdaq)
- Incorporated in
- Israel
- Headquarters
- Ashburn, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671502
- Former names
- Quoin Pharmaceuticals, Ltd. (until Sep 1, 2026); Cellect Biotechnology Ltd. (until Oct 15, 2021); Cellect Biomed Ltd. (until Jul 7, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.